Actinium Pharmaceuticals reported $-5.49M in EBITDA for its fiscal quarter ending in September of 2025.





Ebitda Change Date
AbbVie USD 3.52B 828M Sep/2025
Actinium Pharmaceuticals USD -5.49M 1.81M Sep/2025
Amgen USD 5.14B 775M Dec/2025
Bioline Rx USD -554K 2.93M Sep/2025
Capricor Therapeutics USD -27.23M 2.66M Jun/2025
Pfizer USD 6.08B 351M Sep/2025